F 0550
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Honor the resident's right to a dignified existence, self-determination, communication, and to exercise his or
her rights.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to treat one of 14 residents (8) with respect and
dignity when certified nursing assistant A (CNA A) was standing and feeding Resident 8. This failure had
the potential to cause feeling of low self-esteem for the resident.
Findings:
Review of Resident 8's admission Record indicated she was admitted to the facility on [DATE].
During an observation on 5/28/25, at 12:37 p.m., CNA A was standing and feeding lunch to Resident 8 in
her room.
During a concurrent interview with CNA A, she stated that she did not feel comfortable if she sat down and
fed Resident 8, because she had to reach to Resident 8 to feed her. CNA A acknowledged that she could
adjust the bed level and reposition Resident 8, so that she could reach to Resident 8 comfortably. CNA A
stated she should sit down while feeding Resident 8.
Review of the facility's policy, Promoting/Maintaining Resident Dignity During Mealtimes, dated 10/21/24,
indicated . 5. All staff will be seated, if possible, while feeding a resident.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 29
Event ID:
055646
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0583
Keep residents' personal and medical records private and confidential.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to protect resident's rights to confidentiality for
one of 14 residents (112) when the infection preventionist (IP) left her laptop screen open with Resident
112's face sheet (a document summarizing key patient information, including name, address, date of birth ,
emergency contact, medical history, medications, allergies, and insurance details) open and unattended on
top of the stand in the hallway. This failure had the potential to compromise the resident's privacy and
confidentiality.
Residents Affected - Few
Findings:
Review of Resident 112's admission Record indicated he was admitted to the facility on [DATE].
During an observation on 5/27/25, at 10:55 a.m., the IP was in the hallway. Her laptop was on the stand and
in front of her. The laptop was open with Resident 112's face sheet displayed on the screen. The IP left her
laptop there and walked to the lobby to talk with the maintenance director. Then, the IP walked farther,
across the lobby, to the other hallway to talk with other staff.
During an interview with the IP on 5/27/25, at 10:57 a.m., she confirmed that she left her laptop open with
Resident 112's face sheet open and unattended in the hallway. The IP stated she should close her laptop
before walking away to talk with other staff.
Review of the facility's policy, Health Insurance Portability and Accountability Act (HIPAA, a federal law that
sets a national standard to protect medical records and other personal health information) Security
Measures, dated 5/12/25, indicated . 8. Physical safeguards will be implemented that limit physical access
to its electronic information systems and the facility or facilities in which they are housed, while ensuring
that properly authorized access is allowed.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 2 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's
ability to function.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure two of 14 sampled residents (Resident 39 and
Resident 22) were free from unnecessary psychotropic medication (medications that affect brain activities
associated with mental processes and behaviors) use when:
1. Resident 39 was administered Belsomra (Suvorexant, a sedative hypnotic medication used to treat
insomnia) without informed consent (a process where the resident or their representative is educated about
the risks, benefits, and alternatives to a medication before agreeing to its use), monitoring for sleep or
side-effects, and a care plan addressing the medication's use.
2. Resident 22 did not have an updated informed consent when antipsychotic medication, Perphenazine
(used to treat the symptoms of schizophrenia, a mental illness that causes disturbed or unusual thinking,
loss of interest in life, and strong or inappropriate emotions) dose was increased.
These failures put residents at risk for adverse effects of psychotropic medications.
Findings:
1. A review of Resident 39's admission record indicated the resident was admitted to the facility on [DATE]
with diagnoses that included: depression (a mental health condition that causes persistent sadness and
loss of interest), and schizoaffective disorder (a chronic mental health condition that includes symptoms of
hallucinations or delusions).
A review of Resident 39's Order Summary Report indicated that on 5/19/25, the physician prescribed
Belsomra 10 milligrams (mg, unit of measurement), to be given as one tablet by mouth at bedtime for
insomnia (difficulty sleeping).
A review of Resident 39's clinical records showed no documentation of informed consent before initiating
Belsomra, sleep monitoring or monitoring for side-effects, or a care plan that included the use of Belsomra
or interventions.
During a concurrent interview and record review with the Director of Nursing (DON) on 5/30/25 at 10:30
a.m., the DON confirmed that there was no documented informed consent obtained before Belsomra was
administered to Resident 39. There was no monitoring for sleep or side-effects recorded after the
medication was started. The DON further stated that Resident 39's care plan addressed the problem of
insomnia, but did not include specific interventions related to the use of Belsomra or monitoring its
side-effects.
Review of facility's policy titled Use of Psychotropic Medications, revised date 2/5/25, indicated: .9) Prior to
initiating or increasing psychotropic medication, the resident, family, and/or resident representative must be
informed of the benefits, risks, and alternatives for the medication .the facility will document that the
resident or resident representative was informed in advance of the risks and benefits of the proposed care,
the treatment alternatives or other options and the preferred option to accept or decline .14) The effects of
the psychotropic medications on a resident's physical, mental, and psychosocial well-being will be evaluate
on an ongoing basis, such as .d) In accordance with nurse assessments and medication monitoring
parameters consistent with clinical standards
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 3 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
of practice, manufacturer's specifications, and the resident's comprehensive plan of care. 15) The resident's
response to the medication(s), including progress towards goals and presence/absence of adverse
consequences, shall be documented in the resident's medical record .
2. A review of Resident 22's clinical records indicated an initial admission date of 9/17/24 and diagnoses
included, bipolar disorder, unspecified (a mental health condition where a person experiences extreme
shifts in mood, energy, and activity levels, moving between periods of intense happiness and energy
[mania] and periods of sadness and low energy [depression]) and, schizophrenia, unspecified (a chronic
brain disorder that affects how a person thinks, feels, and behaves, leading to a disconnection from reality).
A review of Resident 22's Physician order dated 5/9/25 indicated, Perphenazine Oral tablet 8 MG Give 2
tablet by mouth two times a day for Schizophrenia
During a concurrent interview and record review of Resident 22's clinical records with the DON on 5/30/25
at 12:06 p.m., the DON verified Resident 22 did not have an updated informed consent for the current
Perphenazine dose. The DON verified, the informed consent indicated Perphenazine 5 mg to be given 2
tablets twice daily.
A review of the facility's policy and procedure (P&P) entitled, Use of Psychotropic Medication (s) revised on
2/5/25, the P&P indicated, .9. Prior to initiating a psychotropic medication, the resident, family, and/or
resident representative must be informed of the benefits, risks, and alternatives for the medication,
including any black box warnings for antipsychotic medications, in advance of such initiation or increase .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 4 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
Based on interview and medical record review, the facility failed to develop and implement a comprehensive
person-centered plan of care for two out of 14 sampled residents (Residents 48 and 22) when:
Residents Affected - Few
1. Resident 48 did not have a comprehensive care plan specific to the medication Aripiprazole (an
antipsychotic medication used to treat several mental health conditions) and interventions indicated in the
care plan were not followed.
2. Resident 22 did not have a comprehensive care plan specific to the medication Perphenazine (used to
treat the symptoms of schizophrenia, a mental illness that causes disturbed or unusual thinking, loss of
interest in life, and strong or inappropriate emotions).
These failures put residents at risk for inadequate monitoring of possible adverse effects specific to their
antipsychotic medications.
Findings:
1. A review of Resident 48's clinical record indicated an admission date of 3/25/25 and diagnoses included
anxiety disorder, unspecified (a mental health condition where excessive worry, fear, and apprehension
interfere with daily life), depression (a common mental health condition characterized by persistent feelings
of sadness, hopelessness, and loss of interest in previously enjoyable activities), and unspecified mood
[affective] disorder (a mental health condition characterized by persistent and significant changes in a
person's mood, thoughts, and behaviors).
A review of Resident 48's Physician Order indicated, Abilify Oral Tablet 5 MG [milligram, a unit of
measurement] (Aripiprazole) Give 1 tablet by mouth at bedtime for UNSPECIFIED MOOD [AFFECTIVE]
DISORDER M/B mood swing, hallu [hallucinations] GDR [gradual dose reduction, tapering of a dose to
determine if symptoms, conditions, or risks can be managed by a lower dose] ordered on 5/13/25.
A review of Resident 48's nursing care plan interventions initiated on 3/26/25 indicated, Complete AIMS
[Abnormal Involuntary Movement Scale, used to assess the presence and severity of unwanted, involuntary
movements in patients, particularly in areas like the face, mouth, limbs, and trunk] assessment every 6
months and with each increase in dose of antipsychotics
During a concurrent interview and record review of Resident 48's clinical records with the Director of
Nursing (DON) on 5/30/25 at 11:50 a.m., the DON verified there was no care plan specific for the
medication Aripiprazole. The DON also verified Resident 48 did not have a baseline AIMS. The DON also
verified Aripiprazole had a black box warning (the strongest warning the U.S. Food and Drug Administration
(FDA) can place on a drug label. It indicates a serious, life-threatening side effect or a high risk of harm
associated with the medication).
During a concurrent interview and record review on 5/30/25 at 3:41 p.m. with the pharmacist consultant
(PC), the PC stated a baseline AIMS would be appropriate.
A review of facility's policy and procedure (P&P) entitled, Use of Psychotropic Medication (s) revised on
2/5/25, the P&P indicated, .13. AIMS monitors Parkinsonian Symptoms [problems with movement, including
shaking (tremor), stiffness (rigidity), and slow movement (bradykinesia), as well as
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 5 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
balance issues] such as Extrapyramidal symptoms [side effects caused by certain medications, particularly
antipsychotics, that affect the motor system] 14. The effects of psychotropic medications on a resident's
physical, mental, and psychosocial well-being will be evaluated on an ongoing basis such as: d. In
accordance with the nurse assessments and medication monitoring parameters consistent with the clinical
standards of practice, manufacturer's specifications, and the resident's comprehensive plan of care .
Residents Affected - Few
A review of facility's policy and procedure (P&P) entitled Resident Rights revised on 3/4/25, the P&P
indicated, .2. Planning and implementing care .a .iv. The right to receive the services and/or times included
in the plan of care.
2. A review of Resident 22's clinical records indicated an initial admission date of 9/17/24 and diagnoses
included, bipolar disorder, unspecified (a mental health condition where a person experiences extreme
shifts in mood, energy, and activity levels, moving between periods of intense happiness and energy
[mania] and periods of sadness and low energy [depression]) and, schizophrenia, unspecified (a chronic
brain disorder that affects how a person thinks, feels, and behaves, leading to a disconnection from reality).
A review of Resident 22's Physician order dated 5/9/25 indicated, Perphenazine Oral tablet 8 MG Give 2
tablets by mouth two times a day for Schizophrenia
During a concurrent interview and record review of Resident 22's clinical records with the DON on 5/30/25
at 12:06 p.m., the DON verified, there was no nursing care plan specific for Perphenazine. The DON stated
specific medications were not included in the nursing care plan. The DON also verified Resident 22 had
nursing care plans specific to other psychotropic medications (drugs that affect the brain and are used to
treat mental health conditions like depression, anxiety, and schizophrenia) such as Bupropion (medication
primarily used as an antidepressant ) and Sertraline (medication primarily used as an antidepressant).
A review of facility's policy and procedure (P&P) entitled, Use of Psychotropic Medication (s) revised on
2/5/25, the P&P indicated, . 14. The effects of psychotropic medications on a resident's physical, mental,
and psychosocial well-being will be evaluated on an ongoing basis such as: d. In accordance with the nurse
assessments and medication monitoring parameters consistent with the clinical standards of practice,
manufacturer's specifications, and the resident's comprehensive plan of care .
A review of facility's policy and procedure (P&P) entitled, Comprehensive Care Plans revised 2/5/25, the
P&P indicated, It is the policy of this facility to develop and implement a comprehensive person-centered
care plan for each resident, consistent with resident rights, that includes measurable objectives and
timeframes to meet a resident's medical, nursing, and mental and psychosocial needs and ALL services
that are identified in the resident's comprehensive assessment and meet professional standards of quality .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 6 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the residents received the necessary care and
services for one of 14 residents (112) when Resident 112 was admitted with a pacemaker (electric
activity-generating device used to treat patients with slow heart rates) but there was no information on the
pacemaker found in his clinical record. This failure had the potential to negatively affect the resident's
health, well-being, and safety.
Residents Affected - Few
Findings:
Review of Resident 112's admission Record indicated he was admitted to the facility on [DATE].
Review of Resident 112's physician order, dated 5/22/25, indicated Resident 112 had a pacemaker.
However, there were no information on the pacemaker such as the cardiologist information, the implant
date, the device model, device serial number, lead (a wire that connects a pacemaker to the heart) model,
lead serial number, battery longevity, device lower rate and maximum rate, and device checkup period
found in Resident 112's clinical record.
During an interview with the director of nursing (DON) on 5/30/25, at 2:30 p.m., she reviewed Resident
112's clinical record and was unable to find the information on his pacemaker. The DON stated she would
request Resident 112's pacemaker information and keep them in his clinical record.
Review of the facility's 2024 policy, Use of Pacemaker, indicated . 4. All documentation about the
pacemaker will be placed in the residents' chart and part of their permanent record.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 7 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the residents receive the pain management
according to their pain levels for one of two residents (53) when the licensed nurses administered Norco
(used to relieve severe pain) 5-325 milligrams (mg, a metric unit of mass) to Resident 53 when she did not
have severe pain. This failure had the potential for Resident 53 to experience unnecessary adverse effects
from the pain medication.
Residents Affected - Few
Findings:
Review of Resident 53's admission Record indicated she was admitted to the facility on [DATE] with
aftercare following joint replacement surgery diagnosis.
Review of Resident 53's physician order, dated 5/1/25, indicated she had an order for Norco 5-325 mg one
tablet every 4 hours as needed for severe pain level 7-10.
Review of Resident 53's 5/2025 Medication Administration Record (MAR) indicated the licensed nurses
administered Norco 5-325 mg one tablet to Resident 53 when her pain level was less than 7 on 5/4/25 at
5:09 a.m., 5/6/25 at 9:22 a.m., 5/9/25 at 05:02 a.m., 5/9/25 at 9:45 a.m., 5/10/25 at 9:56 a.m., 5/12/25 at
10:35 a.m., 5/13/25 at 9:06 a.m., 5/13/25 at 2:40 p.m., 5/14/25 at 1:07 a.m., 5/14/25 at 5:42 a.m., 5/15/25
at 8:51 a.m., 5/17/25 at 9:30 a.m., 5/17/25 at 6:25 p.m., 5/18/25 at 4:36 a.m., 5/18/25 at 11:12 a.m.,
5/18/25 at 8:19 p.m., 5/20/25 at 5:10 a.m., 5/24/25 at 7:59 p.m., 5/25/25 at 2:33 p.m., 5/26/25 at 4:37 a.m.,
5/26/25 at 8:34 a.m., 5/26/25 at 1:57 p.m., and on 5/27/25 at 4:35 a.m.
During an interview with the director of nursing (DON) on 5/30/25, at 2:43 p.m., she reviewed Resident 53's
5/2025 MAR and confirmed that the licensed nurses administered Norco 5-325 mg one tablet to Resident
53 when her pain level was less than 7 on 5/4/25 at 5:09 a.m., 5/6/25 at 9:22 a.m., 5/9/25 at 05:02 a.m.,
5/9/25 at 9:45 a.m., 5/10/25 at 9:56 a.m., 5/12/25 at 10:35 a.m., 5/13/25 at 9:06 a.m., 5/13/25 at 2:40 p.m.,
5/14/25 at 1:07 a.m., 5/14/25 at 5:42 a.m., 5/15/25 at 8:51 a.m., 5/17/25 at 9:30 a.m., 5/17/25 at 6:25 p.m.,
5/18/25 at 4:36 a.m., 5/18/25 at 11:12 a.m., 5/18/25 at 8:19 p.m., 5/20/25 at 5:10 a.m., 5/24/25 at 7:59 p.m.,
5/25/25 at 2:33 p.m., 5/26/25 at 4:37 a.m., 5/26/25 at 8:34 a.m., 5/26/25 at 1:57 p.m., and on 5/27/25 at
4:35 a.m. The DON stated the licensed nurses should administer pain medication to the residents
according to the pain level as ordered by the physician.
Review of the facility's job description, Registered Nurse, dated 11/13/17, indicated . Medication and
Treatment Administration Functions: . Complies with professional standards, policies and procedures, and
legal documentation principles for administering medications, treatments, enteral, and intravenous
therapies.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 8 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0700
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Try different approaches before using a bed rail. If a bed rail is needed, the facility must (1) assess a
resident for safety risk; (2) review these risks and benefits with the resident/representative; (3) get informed
consent; and (4) Correctly install and maintain the bed rail.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure the proper use of side rails or bed rails
(adjustable rigid bars attached to the side of a bed) for two of 20 residents who used side rails, (Residents
19 and 28), when their side rail assessments (determine the appropriateness and safety of using side rails
on a bed for an individual) were not updated in a timely manner.
This failure had the potential to place the residents at risk for entrapment (danger for the resident, being
caught, trapped or entangled in the gap, space or opening) that may lead to injury or death.
Findings:
1. During an observation of Resident 19, on 5/27/25 at 10:38 a.m., Resident 19 was in bed, alert, calm,
comfortable and verbally responsive. Resident 19's one fourth (quarter) side rail was up.
Review of Resident 19's admission record (document created when a resident is admitted to a healthcare
facility, containing the vital information about the resident), indicated, Resident 19 was readmitted to the
facility on [DATE] with the primary diagnosis of unspecified arthropathic psoriasis (long-term inflammatory
arthritis that may occur in some people affected by the autoimmune disease psoriasis).
Review of Resident 19's physician orders indicated, Resident 19 had an order on 2/21/24 for side rails for
prompt bed mobility.
Review of Resident 19's side rail assessment indicated, it was last updated on 2/12/25.
During the concurrent review of the side rail assessment of Resident 19 and interview with the Director of
Nursing (DON), on 5/30/25 at 1:05 p.m., the DON acknowledged that the side rail assessment of Resident
19 was not updated regularly or quarterly. The DON further acknowledged that Resident 19's side rail
assessment was last updated on 2/12/25 and it should have been updated already at this time.
2. During an observation of Resident 38, on 5/27/25 at 10:30 a.m., Resident 38 was laying in his bed, alert,
calm, comfortable and verbally responsive. Resident 38 had his bilateral (both sides), half side rails up.
Review of Resident 38's admission record indicated, Resident 38 was readmitted to the facility on [DATE]
with the primary diagnosis of unspecified displaced fracture (occurs when bone is broken and the broken
pieces are not aligned) of third cervical vertebra (part of the seven vertebrae that makes up the neck),
subsequent encounter for fracture with routine healing (healing of the fracture is progressing as expected).
Review of Resident 38's physician orders indicated, Resident 38 had an order on 2/12/25 for side rails for
bed mobility.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 9 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0700
Review of Resident 38's side rail assessment indicated, it was last updated on 1/7/25.
Level of Harm - Minimal harm
or potential for actual harm
During the concurrent review of the side rail assessment of Resident 38 and interview with the DON, on
5/30/25 at 1 p.m., the DON verified that the side rail assessment of Resident 38 was not updated regularly
or quarterly. The DON further verified that Resident 38's side rail assessment was last updated on 1/7/25
and it should have been updated already.
Residents Affected - Few
Review of the facility's policy and procedure titled, Proper Use of Bed Rails, implemented on October 2022
indicated, It is the policy of this facility to utilize a person-centered approach when determining the use of
bed rails .The facility will continue to provide necessary treatment and care to the resident who has bed
rails in accordance with professional standards of practice and the resident's choices .Responsibilities of
ongoing monitoring and supervision are specified as follows: A nurse assigned to the resident will complete
reassessments in accordance with the facility's assessment schedule, but not less than quarterly, upon
significant change in status, or change in the type of bed/mattress/rail .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 10 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the effective use of medications for one of 14
residents (112) when Resident 112 received Ferosul (iron, used for prevention/treatment of iron deficiency)
and Calcium Citrate (a medication used to prevent or treat low blood calcium levels) at the same time. This
failure had the potential for the residents to not receive the amount of prescribed iron supplements.
Findings:
Review of Resident 112's admission Record indicated he was admitted to the facility on [DATE].
Review of Resident 112's clinical record indicated, he had physician orders for Ferosul 325 milligrams (mg,
a metric unit of mass) every 48 hours for anemia (a problem of not having enough healthy red blood cells to
carry oxygen to the body's tissues) at 9 a.m., started on 5/23/25, and for Calcium Citrate 250 mg every day
at 9 a.m. and 5 p.m., started on 5/22/25. Thus, since 5/23/25, Ferosul and Calcium Citrate were given at the
same time at 9 a.m. every 48 hours.
During an interview with the pharmacist consultant (PC) on 5/30/25, at 1:56 p.m., she stated Ferosul and
Calcium Citrate should be administered at least two hours apart due to drug-to-drug interaction that
decreases the absorption of iron.
According to Lexicomp (www.[NAME].com), a nationally recognized drug information resource, the
concurrent use of calcium and ferrous sulfate led to a drug-drug interaction (DDI) of Risk Rating D, which
was a significant interaction and required therapy modification. The effect of DDI was that the calcium may
decrease the absorption of oral preparations of iron salts. It indicated the iron absorption decreased an
average of 60% when given as ferrous sulfate and co-administered with calcium. Lexicomp also indicated to
separate the administrations of these medications so it may minimize the potential for significant interaction.
Review of the facility's 2023 policy, Adverse Drug Interactions, indicated The pharmacy will perform an
initial assessment of the complete medication profile for potential adverse drug interactions and other
contraindications or precautions on all new patient orders at the time of admission. The pharmacy will
perform continual and ongoing assessment of the complete medication profile for adverse interactions and
other contraindications for each new order received thereafter.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 11 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart,
following irregularity reporting guidelines in developed policies and procedures.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the pharmacist consultant's recommendation was
acted upon for one of 14 residents (115) when Resident 115's administration record on alendronate (used
to prevent and treat osteoporosis [thinning of the bone]) did not include the information the pharmacist
consultant asked to be included. This failure had the potential for Residents 115 to receive ineffective
medication and adverse effects that could negatively impact her health and well-being.
Findings:
Review of Resident 115's admission Record indicated she was admitted to the facility on [DATE] with
osteoporosis diagnosis.
Review of Resident 115's Consultation Report, dated 5/20/25, indicated the pharmacist consultant
recommended to include in Resident 115's administration record on alendronate the following information:
Administer intact tablet at least 30 minutes before the first food, beverage, or medication of the day with 6 to
8 ounces of plain water. Individuals should not lie down for at least 30 minutes and until after the first food
of the day. However, review of Resident 115's administration record on alendronate did not indicate that the
pharmacist consultant's recommendation was included.
During an interview with the director of nursing (DON) on 5/30/25, at 2:47 p.m., she reviewed Resident
115's clinical record and confirmed that the pharmacist consultant's recommendation for her alendronate
was not acted upon.
Review of the facility's policy, Medication Regimen Review (MRR), dated 4/9/25, indicated . Policy
Explanation and Compliance Guidelines: . 7. Timelines and responsibilities for MRR: . f. Facility staff shall
act upon all recommendations according to procedures for addressing medication regimen review
irregularities.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 12 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure one of 6 residents (112) were free from
unnecessary medications when Resident 112 received dabigatran etexilate mesylate (a blood thinner to
prevent blood clots) but was not monitored for the side effects and not care-planned on the use of the
medication. This failure had the potential for Resident 112 to experience unrecognized adverse effects.
Residents Affected - Few
Findings:
Review of Resident 112's admission Record indicated he was admitted to the facility on [DATE].
Review of Resident 112's physician order, dated 5/23/25, indicated he had an order for dabigatran etexilate
mesylate 110 milligrams (mg, a metric unit of mass) two times a day. However, review of Resident 112's
clinical record did not indicate that Resident 112 was monitored for the side effects and was care-planned
on the use of the medication.
During an interview with the director of nursing (DON) on 5/30/25, at 2:26 p.m., she reviewed Resident
112's clinical record and confirmed that Resident 112 was not monitored for the side effects and was not
care-planned on the use of the medication.
Review of the facility's policy, Anticoagulant Therapy, dated 8/2014, indicated . Procedure: . 5. Monitor for
signs and symptoms of adverse drug effects, including, but not limited to, abnormal or prolonged bleeding,
excessive bruising, blood in stool or urine, coffee ground emesis, bleeding from eyes, nose, or gums, etc. 8.
Include anticoagulant use and monitoring in care plan.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 13 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility had a 12% medication error rate when three
medication errors out of 25 opportunities were observed during a medication pass for three out of five
sampled residents (Residents 44, Resident 2, and Resident 8) when:
Residents Affected - Few
1. Resident 44 did not receive Calcium Carbonate with Vitamin D tablet (used to treat conditions caused by
low calcium levels such as bone loss) as ordered by the physician.
2. Resident 2 received Diroximel Fumarate capsule (medication used for the treatment of relapsing forms of
multiple sclerosis, a disease that causes breakdown of the protective covering of nerves) without food.
3. Resident 8 did not receive Fluticasone-Salmeterol inhalation (used to treat difficulty breathing, wheezing,
shortness of breath, coughing, and chest tightness caused by asthma) as ordered by the physician.
These failures resulted in medications not given in accordance with the manufacturer's instructions and/or
physician's order and had the potential for residents not receiving the full therapeutic effects of medications.
Findings:
1. During a medication pass observation on 5/27/25 at 11:27 a.m. with Registered Nurse (RN) E, RN E was
preparing medications for Resident 44. RN E stated Resident 44 is due to have Calcium Carbonate with
Vitamin D but was not available. RN E also stated pharmacy and physician will be notified.
A review of Resident 44's Physician Order dated 5/12/25 indicated, Calcium 600 + D oral tablet 500-5
mg-mcg [milligram-microgram, units of measurement] (calcium carbonate-vitamin D) give 1 tablet by mouth
three times a day for supplement.
During a concurrent interview and record review of Resident 44's Medication Administration Record (MAR)
for May 2025 with the Director of Nursing (DON) on 05/29/25 at 3:44 p.m., the DON verified Calcium
Carbonate with Vitamin D was not given at 9 a.m. and 1 p.m. on 5/27/25.
A review of facility's policy and procedure (P&P) entitled, Medication Administration revised 4/9/25, the P&P
indicated, Medications are administered by licensed nurses, or other staff who are legally authorized to do
so in this state, as ordered by the physician and in accordance with professional standards of practice .
2. During a medication pass observation on 5/28/25 at 4:03 p.m. with Licensed Vocational Nurse (LVN) F,
LVN F was preparing medications for Resident 2 which included, Gabapentin (a medication primarily used
as an anticonvulsant) 300 mg (milligram, unit of measurement) tablet, Sucralfate (medication that treats
stomach ulcers) 1 gram tablet, and 2 capsules of Diroximel Fumarate 231 mg. Resident 2 took the
medications with a glass of water. There was no food tray observed on Resident 2's table.
A review of Resident 2's physician order indicated, Vumerity Capsule delayed release 231 mg [milligram,
unit of measurement] (diroximel fumarate) give 2 capsules by mouth two times a day for multiple sclerosis,
administer at least 20 minutes after food is taken.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 14 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During a concurrent interview and record review of Resident 2's clinical record with the DON, the DON
verified diroximel fumarate was scheduled to be given before dinner. The DON stated the nurse should
have asked if Resident 2 had taken food. The DON also stated the medication must be scheduled after
meals or a snack should be offered prior to administration.
A review of facility's policy and procedure (P&P) entitled, Medication Administration revised 4/9/25, the P&P
indicated, .17. Administer medication as ordered in accordance with manufacturer specifications. a. Provide
appropriate amount of food and fluid .
3. During a medication pass observation on 5/28/25 at 4:09 p.m. with Licensed Vocational Nurse (LVN) F,
LVN F prepared medication for Resident 8 which included, Calcium with Vitamin D3 tablet. LVN F stated
Resident 8 was due for a breathing treatment that was not available. Resident 8 took Calcium with Vitamin
D3 tablet with a glass of water.
A review of Resident 8's physician order indicated, Wixela Inhub Aerosol Powder Breath Activated 250-50
mcg/act [microgram per actuation, a unit of measurement] (fluticasone-salmeterol) 1 puff inhale orally two
times a day for asthma rinse mouth after each dose.
During a concurrent interview and record review of Resident 8's clinical records with the DON on 5/29/25 at
3:44 p.m., the DON verified fluticasone-salmeterol inhalation was not administered for Resident 8 on
5/28/25 due at 5 p.m.
A review of facility's policy and procedure (P&P) entitled, Medication Administration revised 4/9/25, the P&P
indicated, Medications are administered by licensed nurses, or other staff who are legally authorized to do
so in this state, as ordered by the physician and in accordance with professional standards of practice .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 15 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to ensure medications and biologicals
were stored appropriately and in good sanitary condition when:
1. Medication refrigerator had ice build up in the freezer and had a streak of yellowish-brown substance on
the shelf bracket.
2. Five expired over-the-counter medications, and an opened bottle of medication for a discharged resident
were found in the Central Supply Room.
These failures put residents at risk for contaminated medications and had the potential for residents to
receive outdated and/or ineffective medications which could lead to residents not receiving the full benefit
of the medications and negative health outcomes.
Findings:
1. During an inspection of the medication room on 5/27/25 at 10:21 a.m. with the Director of Nursing (DON),
a mini refrigerator was inside. The DON confirmed there was an ice buildup in the freezer. The DON verified
the ice buildup blocked the freezer door and cannot be closed and was hard to open. The DON also verified
there was a streak of yellowish-brown substance found inside refrigerator on the right shelf bracket. The
DON stated, We could clean it better.
A review of facility's policy and procedure (P&P) entitled Medication Storage revised 4/9/25, the P&P
indicated, It is the policy of this facility to ensure all medications housed on our premises will be stored in
pharmacy and/or medication rooms according to the manufacturer's recommendations and sufficient to
ensure proper sanitation, temperature, light, ventilation, moisture control, segregation, and security .
2. During an inspection of the Central Supply Room (CSR) on 5/27/25 at 10:30 a.m. with the DON, the
DON stated over-the-counter medications and other supplies were stored in the CSR. The DON confirmed
the following were stored in the CSR:
a. A bottle of Vitamin D3 125 mcg (microgram, unit of measurement) capsules with expiration date 1/2025.
b. 2 bottles of Acetaminophen 325 mg (milligram, unit of measurement) tablets with expiration date
12/2024.
c. A bottle of Acetaminophen 325 mg (milligram, unit of measurement) tablets with expiration date 8/2024
d. A tube of Zinc Oxide Formula non greasy barrier cream with expiration date 3/2025
e. An opened bottle of Pancrelipase capsules (used to improve digestion of food for people who have a
condition in which the pancreas does not have enough enzymes needed to break down food so it can be
digested) labeled with a discharged resident's name.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 16 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
The DON stated she did not know why the expired medications were there. The DON also confirmed the
opened bottle of Pancrelipase belonged to a discharged resident and should not have been there.
A review of facility's policy and procedure (P&P) entitled Medication Storage revised 4/9/25, the P&P
indicated, .8. Unused Medications: The pharmacy and all medication rooms are routinely inspected by the
consultant pharmacist for discontinued, outdated, defective, or deteriorated medications with worn, illegible,
or missing labels. These medications are destroyed in accordance with our Destruction of Unused Drugs
Policy.
Event ID:
Facility ID:
055646
If continuation sheet
Page 17 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0804
Ensure food and drink is palatable, attractive, and at a safe and appetizing temperature.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview and record review, the facility failed to ensure palatability and temperature
of the foods served were maintained when:
Residents Affected - Many
1. The pureed (a smooth, thick liquid or paste made by crushing or grinding solid foods using a blender or
food processor) fish and pureed bread tasted bland (lacking taste or flavor); and
2. The temperature of the hot foods served were below the desired level.
These failures could lead to decreased nutrient intake for the 55 facility residents receiving food from the
kitchen.
Findings:
1. During the test tray observation and tasting with the dietary manager (DM), on 5/28/25 at 12:45 p.m. to
12:52 p.m., two test plates in the trays were brought and tasted. One of the test plates contained regular
(no modification or restriction) fish, regular vegetables and regular orzo (type of short-cut pasta that is
shaped like a large grain of rice). The second test plate contained pureed fish, pureed bread, pureed
vegetables and pureed orzo (pasta). Tasted the pureed foods after and the pureed fish and pureed bread
had no taste or tasted bland.
During an interview with the DM after he tasted the test plate with pureed foods, on 5/28/25 at 12:53 p.m.,
the DM acknowledged that the pureed fish and pureed bread, tasted bland. The DM further acknowledged
that he would follow up on this concern and on improving the taste of these pureed foods.
During an interview with the registered dietitian (RD), on 5/29/25 at 2:35 p.m., the RD verified that the foods
to be served to the residents should be palatable and not bland in taste. The RD further verified that he
would check on this concern.
Review of the facility's policy titled, Food and Dining Services Policies and Procedures: Resident Food
Preferences, effective 11/2016 indicated, Satisfy resident's tastes and appetites by determining their food
preferences at meals .
Review of the facility's policy titled, Food and Dining Services Policies and Procedures: Recipes, effective
2/2009 indicated, Ensure consistent food and dining quality .
Review of the facility's policy and procedure titled, Food and Dining Services Policies and Procedures:
Resident Food Acceptability, effective 2/2009 indicated, Resident's acceptance of the menu and food is
monitored routinely. All food and dining services staff and nursing staff are responsible for monitoring
resident meal satisfaction .
2. During the test tray observation and tasting with the DM, on 5/28/25 at 12:45 p.m., the DM checked the
temperatures of the foods in the two test plates in the trays that were brought, before they were tasted. The
temperatures of the following hot foods were below 135 degrees Fahrenheit (F, temperature scale), which
was the required temperature of the hot foods to be served in the facility:
a. regular fish - 134 degrees F;
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 18 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0804
b. regular vegetable - 125 degrees F;
Level of Harm - Minimal harm
or potential for actual harm
c. puréed fish - 122 degrees F;
d. puréed orzo - 117 degrees F and
Residents Affected - Many
e. puréed bread - 114 degrees F.
During an interview with the DM on 5/29/25 at 4:35 p.m., the DM verified that the hot foods to be served to
the residents should be 135 degrees F or above and temperatures of the regular fish, regular vegetables,
pureed fish, pureed orzo and pureed bread were below 135 degrees F and would follow up on this concern.
During an interview with the RD on 5/29/25 at 5:03 p.m., the RD verified that hot foods served to residents
should be 135 degrees F or above and would check on that issue.
Review of the facility's policy and procedures titled, Food and Dining Services Policies and Procedures:
Safe Food Temperatures, effective 2/2009 indicated, Food temperatures are maintained at acceptable
levels during food storage, preparation, holding, service, delivery Hot foods will be held at 135 degrees F or
higher during meal service (on the tray line) .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 19 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Many
Procure food from sources approved or considered satisfactory and store, prepare, distribute and serve
food in accordance with professional standards.
Based on observation, interview, and record review, the facility failed to ensure, cooking and kitchen
equipment were maintained properly and foods in the kitchen were prepared in accordance with
professional standards for food safety when:
1. There were unsanitary cooking and kitchen equipment stored in the kitchen and,
2. Kitchen staff did not perform hand hygiene and sanitation during the tray line preparation.
These failures had the potential to cause the growth of micro-organisms which could cause foodborne
illness (illness resulting from contaminated food) and cross-contaminated food for the 55 residents who
received food from the facility kitchen.
Findings:
1. During the initial kitchen tour observation with the dietary manager (DM), on 5/27/25 at 9:25 a.m.,
observed 5 large cooking pans with brownish to blackish discolorations and rusty spots in them.
During an interview with the DM on 5/27/25 at 9:26 a.m., the DM acknowledged that the 5 large cooking
pans had brownish to blackish discolorations and rusty spots and had them removed right away. He then
stated that he would have them replaced.
During an interview with the registered dietitian (RD), on 5/29/25 at 2:35 p.m., the RD verified that the 5
large cooking pans with brownish to blackish discolorations and rusty spots should not be kept there in the
kitchen and should have been replaced. The RD then stated that he would follow-up on that concern.
2. During the tray line preparation observation on 5/28/25 at 12:10 p.m., dietary aide C (DA C) helped in
filling out the liquids of the resident meal trays in the tray carts. Observed DA C, went out of the kitchen still
wearing her gloves, then went back inside and proceeded to help right away with the tray line preparation
without removing her used gloves, doing hand washing and putting on new gloves before going back to
helping with the tray line preparation.
During an interview with DA C on 5/28/25 at 2:35 p.m., DA C verified that she should have removed her
gloves, washed her hands and put on new gloves, before she continued helping with the tray line
preparation, when she went out of the kitchen and then came back right after.
During an interview with the DM on 5/28/25 at 12:55 p.m., the DM verified that DA C should have removed
her used gloves, should have done hand washing and should have put on new gloves after she went out of
the kitchen and before helping back with the tray line preparation, when she came back.
During an interview with the RD on 5/29/25 at 2:35 p.m., the RD verified the above concern. The RD stated
that he would remind the kitchen staffs about proper hand hygiene and sanitation.
Review of the facility's policy and procedure titled, Food and Dining Services Policies and Procedures:
Personnel Sanitation Standards, effective 2/2009 indicated, Maintain sanitation among food and dining
services personnel. Food and dining services personnel follow sanitary standards and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 20 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
practices . Hands must be washed after each trip to the restroom, after leaving storage rooms, washrooms,
etcetera .
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Many
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 21 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2a. Review of
Resident 53's admission Record indicated she was admitted to the facility on [DATE].
Residents Affected - Some
Review of Resident 53's physician order, dated 5/25/25, indicated she had an order for oxygen 2-3 liters per
minute (LPM) as needed for shortness of breath.
During an observation and interview with the infection preventionist (IP) on 5/27/25, at 10:46 a.m., the filter
of Resident 53's oxygen concentrator was dusty. The IP confirmed the filter was dusty and stated the filter
should be cleansed every week.
2b. Review of Resident 112's admission Record indicated he was admitted to the facility on [DATE].
Review of Resident 112's physician order, dated 5/22/25, indicated he had an order for oxygen 2-3 LPM
continuous every shift.
During an observation and interview with the IP on 5/27/25, at 10:51 a.m., the filter of Resident 112's
oxygen concentrator was dusty. The IP confirmed the filter was dusty and stated the filter should be
cleansed every week.
Review of the facility's policy, Oxygen Concentrator, dated 12/3/24, indicated . 5. Care of the Concentrator:
a. Follow manufacturer recommendations for the frequency of cleaning filters and servicing the device. f.
Oxygen concentrators should have a preventive maintenance.
3. During an observation on 5/27/25, at 10:12 a.m., certified nursing assistant B (CNA B) put on gloves,
picked up trash bag in Resident 12's room, walked out of the room to throw the trash bag in the hamper
which was parked on the other side in the hallway with gloves on her hands. CNA B came back to Resident
12's room and prepared his bed with the same gloves on her hands. Resident 12 stated he needed mouth
wash. CNA B removed her gloves but did not sanitize her hands, walked out of the room to get mouth wash
from the supply room for the resident.
During a concurrent interview with CNA B, she stated she should have the hamper at the resident's room
door, so she did not have to walk out in the hallway to throw the trash. CNA B stated she should remove her
gloves and sanitize her hands when walking out of the resident room and in the hallway.
During an interview with the IP on 5/30/25, at 3:02 p.m., she stated staff should not walk out of resident
room with gloves on and should sanitize their hands after removing the gloves.
4. During an observation on 5/28/25, at 12:28 p.m., certified nursing assistant A (CNA A) sanitized her
hands, put on gloves, moved Resident 212's bed, pulled Resident 212 up, repositioned Resident 212 in
bed, and raised Resident 212's head of bed up. CNA A removed her gloves and held the used gloves in her
hand. Without sanitizing her hands, CNA A opened the straw and put it in Resident 212's glass of cranberry
juice, removed the cover of the fruit cup, removed the lid of the lunch plate, picked up the spoon and
pressed on the rice on the lunch plate with the spoon, then walked out of Resident 212's room and in the
hallway to place the lid of the plate in the lunch cart without sanitizing her hands.
During a concurrent interview with CNA A, she stated she should throw the gloves in the trash can,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 22 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
sanitize her hands before assisting the resident with meal and when walking out of the resident room.
Level of Harm - Minimal harm
or potential for actual harm
During an interview with the IP on 5/30/25, at 3:08 p.m., she stated staff should sanitize their hands before
assisting the resident with meal and when walking out of the resident room.
Residents Affected - Some
Review of the facility's policy, Personal Protective Equipment (PPE), dated 6/4/24, indicated . 4.
Indications/considerations for PPE use: a. Gloves: . ii. Perform hand hygiene before donning gloves and
after removal. Gloves are not a substitute for hand hygiene. iv. Change gloves and perform hand hygiene
between clean and dirty tasks, when moving from one body part to another, when heavily contaminated, or
when torn. vii. Dispose of gloves in appropriate waste receptacle.
Based on observation, interview, and record review, the facility failed to implement infection control
measures when:
1. Licensed vocational nurse F (LVN F) did not do hand hygiene in between administration of medications
for two residents (Resident 2 and Resident 8);
2. The filters of Resident 53's and Resident 112's oxygen concentrators were dusty;
3. Certified nursing assistant B (CNA B) walked out of Resident 12's room with gloves on and did not
sanitize her hands after removing the gloves; and
4. Certified nursing assistant A (CNA A) did not sanitize her hands before assisting Resident 212 with meal
and when walking out of the resident room.
These failures had the potential to result in the transmission and spread of infection throughout the facility.
Findings:
1. During a medication pass observation on 5/28/25 at 4:08 p.m. with Licensed Vocational Nurse (LVN) F,
LVN F prepared and administered oral medications to Resident 2. LVN F used gloves and did not do hand
hygiene before putting on and after removing gloves. LVN F did not do hand hygiene after administering
medications to Resident 2. At 4:13 p.m., LVN F proceeded to prepare and administer oral medications to
Resident 8. LVN F did not do hand hygiene prior to administration of medications for Resident 8. LVN F also
used gloves for Resident 8 and did not do hand hygiene before wearing and after removing gloves. LVN F
verified she did not do hand hygiene in between administration of medications for Resident 2 and Resident
8 and before wearing and after removing gloves. LVN F stated hand hygiene should have been done.
During an interview on 5/29/25 at 3:44 p.m. with the Director of Nursing (DON), the DON stated, Hand
hygiene must be done during medication pass in between residents.
A review of facility's policy and procedure (P&P) entitled, Hand Hygiene revised 5/29/24, the P&P indicated,
All staff will perform proper hand hygiene procedures to prevent the spread of infection to other personnel,
residents, and visitors .2. Hand hygiene is indicated and will be performed under the conditions listed in, but
not limited to, the attached hand hygiene table:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 23 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Condition:
Level of Harm - Minimal harm
or potential for actual harm
Between resident contacts- Either soap and water or alcohol-based hand rub
Before preparing or handling medications- Either soap and water or alcohol-based hand rub
Residents Affected - Some
.6. Additional considerations: a. The use of gloves does not replace hand hygiene. If your task requires
gloves, perform hand hygiene prior to donning gloves, and immediately after removing gloves .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 24 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Implement a program that monitors antibiotic use.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure that facility staff monitored and documented the
side effects of antibiotic (ATB, medication that fight bacteria) therapy for seven out of 11 residents
(Residents 165, 9, 57, 267, 15, 269, and 212) who were receiving antibiotics. This failure had the potential
to result in unrecognized adverse drug reactions or inappropriate antibiotic use.
Residents Affected - Some
Findings:
1. A review of Resident 165's admission record indicated the resident was admitted on [DATE] with
diagnoses that included Tuberculosis (TB, an infectitious disease cause by bacteria that primarily affects
the lungs) of lung.
A review of Resident 165's Order Summary Report indicated that on 5/11/25, the physician ordered the
following antibiotics: Levofloxacin (antibiotic used to treat bacteria, including TB) 750 milligrams (mg,unit of
measurement) 1 tablet to be given by mouth (PO) daily for pulmonary (lungs) tuberculosis, Ethambutal
(antibiotic used to treat TB) 400 mg 3 tablets PO daily for right upper lung (RUL) cavitary lesion (an area of
lung tissue damaged by infection) and Linezolid (antibiotic used to treat infection) 600 mg 1 tablet PO daily
for RUL cavitary lesion.
2. A review of Resident 9's admission record showed admission on [DATE] with acute and chronic
respiratory failure with hypoxia (a condition where the lungs cannot get enough oxygen into the blood), and
pneumonia (a lung infection).
A review of Resident 9's Order Summary Report indicated the physician ordered Vancomycin (antibiotic
used to prevent or treat bacterial infection) 50 mg/ml, 2.5 ml PO daily for prophylaxis (a preventive
measure).
3. A review of Resident 57 admission record indicated the resident was admitted on [DATE] with
non-rheumatic aortic valve stenosis (a narrowing of the heart's aortic valve that is not caused by rheumatic
fever).
A review of Resident 57's Order Summary Report indicated the physician ordered Ciprofloxacin (antibiotic
used to treat infection) 250 mg PO twice daily for UTI (infections of the bladder or urinary system).
4. A review of Resident 267's admission record indicated resident was admitted on [DATE] with
osteomyelitis of the thoracic spine (a serious bone infection in the spine) and discitis in multiple spinal
areas (inflammation of the discs between the bones of the spine).
A review of Resident 267's Order Summary Report, dated 5/9/25 included Ceftriaxone (antibiotic used for
serious infections like bone or spine infections) 2 grams (gm, unit of mass) IV (intravenous, administered
into a vein) every 12 hours for discitis (infection in the intervertebral disc space).
5. A review Resident 15's admission record indicated resident was admitted on [DATE] with chronic
obstructive pulmonary disease (COPD, a long-term lung disease that makes it hard to breathe.)
A review of the facility's Antibiotic List dated 5/2025 showed that on 5/28/25, the physician
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 25 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
ordered Cefdinir (an oral antibiotic used to treat respiratory tract infections, including pneumonia) 300 mg
PO twice daily for pneumonia.
6. A review of Resident 269's admission record indicated resident was admitted on [DATE] with aftercare
following a liver transplant (surgical procedure where a diseased or damaged liver is removed and replaced
with a healthy liver from a donor) and cirrhosis of the liver (a condition where the liver is permanently
scarred and cannot function well).
A review of the facility's Antibiotic List, indicated that on 5/21/25, Resident 269 was prescribed Bactrim
(antibiotic used to prevent bacterial infections) 400-80 mg via nasogastric (NG, means the medication is
given through a tube from the nose to the stomach) every Mon, Wed, and Fri as prophylaxis for organ
transplant.
During an interview on 5/29/25 at 4:10 p.m., registered nurse (RN) G stated that nurses assess for rash,
hives, dizziness, or other side effects during antibiotic therapy, and that documentation should be entered in
the MAR (medication administration record) or progress notes.
During a concurrent interview and record review with RN H , evening supervisor, on 5/29/25 at 4:15 p.m.,
RN H stated that facility staff check for allergic reactions, nausea, vomiting, or changes in cognition, and
this should be documented. RN H confirmed no documentation was found for side effect monitoring for the
residents listed above.
During an interview with the Infection Preventionist (IP) on 5/29/25, at 4:33 p.m., the IP stated that nurses
should monitor for side effects while residents are on antibiotics and document those findings.
During an interview with the Director of Nursing (DON) on 5/29/25 at 4:40 p.m., the DON confirmed that
there was no documentation of antibiotic monitoring in the MAR or progress notes for the above residents.
The DON stated that monitoring for side effects should be documented in the progress notes. The DON
further stated that she would educate nursing staff regarding proper documentation of antibiotic therapy
monitoring.
7. During an observation of Resident 212 on 5/27/25 at 10:27 a.m., Resident 212 was laying in his bed,
alert, calm, comfortable and verbally responsive.
Review of Resident 212's admission record (document created when a resident is admitted to a healthcare
facility, containing the vital information about the resident) indicated, Resident 212 was admitted to the
facility on [DATE].
Review of Resident 212's order summary report dated 5/29/25 indicated, Resident 212 had an order of
Ciprofloxacin Hydrochloride (antibiotic used to treat bacterial infections) oral tablet, 500 milligrams (mg, unit
of mass), give 1 tablet by mouth two times a day for urinary tract infection (UTI, an infection that occurs in
any part of the urinary system or the system of organs that makes urine), for 7 days, started on 5/23/25.
During a concurrent review of Resident 212's clinical records and interview with licensed vocational nurse D
(LVN D), on 5/30/25 at 9:43 a.m., LVN D verified that Resident 212 did not have any progress notes (type of
medical record used to document a patient's health status and treatment progress) for his use of
Ciprofloxacin Hydrochloride antibiotic, since it was started on 5/23/25.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 26 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0881
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
During a concurrent review of Resident 212's clinical records and interview with the DON, on 5/30/25 at
1:10 p.m., the DON verified that Resident 212 was on Ciprofloxacin Hydrochloride antibiotic but there was
no progress notes and no monitoring for the side effects of the antibiotic use. The DON further verified that
she would follow up on this concern.
Review of the facility's policy titled, Antibiotic Prescribing Practices, reviewed/revised on 5/29/24 indicated,
Antibiotic use protocols, including prescribing practices, are implemented as part of the facility's Antibiotic
Stewardship Program for the purpose of optimizing the treatment of infections and reducing adverse events
associated with antibiotic use .Random audits of antibiotic prescriptions shall be performed to verify
completeness and appropriateness.
Event ID:
Facility ID:
055646
If continuation sheet
Page 27 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Provide rooms that are at least 80 square feet per resident in multiple rooms and 100 square feet for single
resident rooms.
Based on observation and interview, the facility failed to ensure 17 of 27 bedrooms had at least 80 square
feet per resident. Having less than 80 square feet per resident could potentially compromise the care and
services the residents receive.
Findings:
The room measurement indicated multiple rooms were less than 80 square feet per resident.
Room Number Number of Beds Square Feet
Per Resident
1 3 72.8
5 2 71.37
7 2 71.95
9 2 75
12 3 73.2
14 3 73.2
15 3 73.2
16 3 74
17 3 74
18 2 75
19 2 73.2
20 2 74.4
23 3 73.2
24 3 73.6
25 3 73.6
27 3 73.6
29 3 73.2
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 28 of 29
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055646
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Palo Alto Post-Acute
911 Bryant Street
Palo Alto, CA 94301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
During the survey, residents and staff were observed and interviewed to determine if there were any
concerns or issues with the lack of space or privacy. The residents and staff verbalized no complaints or
concerns regarding space and privacy affecting residents' care.
Recommend to continue room waivers.
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055646
If continuation sheet
Page 29 of 29